Table 2 Assessment of glucose levels in treatment groups treatment trials with Herb-All PARA-X (mg /dL)

w1

20–23

(21 ± 0.9)^b

68–72

(70 ± 1)^{a, A}

33–60

(46 ± 8)^b

46–60

(52 ± 4)^{b, A}

49–52

(56 ± 6)^{b, A}

w2

22–25

(23 ± 0.9)^b

63–68

(65 ± 1)^{a, B}

18–28

(22 ± 3)^b

19–27

(22 ± 2)^{b, B}

18–25

(22 ± 2)^{b, B}

w3

20–26

(24 ± 1.9)^b

52–59

(55 ± 2)^{a, B}

15–17

(18 ± 2)^b

15–25

(19 ± 3)^{b, B}

15–24

(19 ± 3)^{b, B}

w4

18–26

(23 ± 2)^b

40–47

(44 ± 2)^{a, B}

18–22

(19 ± 1)^b

14–28

(20 ± 4)^{b, B}

17–25

(20 ± 3)^{b, B}

P-value

< 0.001

< 0.001

< 0.001